OpenAI AI Researcher & Psychedelic Drug Trial Setbacks | MIT Tech Review
OpenAI is developing an “autonomous AI research intern” slated to begin work by September, according to an exclusive interview with the company’s chief scientist, Jakub Pachocki. The intern will initially tackle a limited set of research challenges, serving as a precursor to a fully automated, multi-agent AI system planned for release in 2028.
Pachocki outlined the project as a significant step toward automating aspects of the research and development process within OpenAI. The initial intern will not replace human researchers, but rather augment their capabilities by handling specific, well-defined problems. The long-term goal, however, is a system capable of independent scientific inquiry.
The announcement comes as interest in the potential of artificial intelligence to accelerate scientific discovery continues to grow. While the field of psychedelic drug research has seen a surge in scientific attention over the past decade, recent clinical trials exploring compounds like psilocybin – found in magic mushrooms – for conditions including depression, PTSD, addiction, and obesity, have yielded disappointing results, suggesting the path to therapeutic application is more complex than initially anticipated.
These recent setbacks, highlighted by studies released this week, underscore the challenges inherent in studying psychedelic substances, and may temper the enthusiasm surrounding their potential. The development of automated AI research tools could offer new avenues for analyzing the complex data generated by such trials, potentially identifying patterns and insights that might otherwise be missed.
The planned multi-agent system, due in 2028, represents a more ambitious undertaking. Such a system would theoretically be capable of formulating its own research questions, designing experiments, and analyzing results with minimal human intervention. The implications of such a system for the pace of scientific progress are substantial, though the technical hurdles remain significant.
News of OpenAI’s AI research intern arrives amid broader shifts in the media landscape. Recent cutbacks at Reach, a major publisher, have impacted senior editorial staff and editors, according to reports. Simultaneously, changes in leadership at CBS News, including the departure of a standards chief described as “woke,” signal a reshaping of the network’s editorial direction. A leaked memo also recently led to the removal of two senior BBC bosses, highlighting the sensitivity surrounding internal communications and editorial standards within major news organizations.